Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Long-Term Investments (2016)

Northwest Biotherapeutics (NWBO) has 7 years of Long-Term Investments data on record, last reported at $77000.0 in Q2 2016.

  • For Q2 2016, Long-Term Investments fell 89.58% year-over-year to $77000.0; the TTM value through Jun 2016 reached $77000.0, down 89.58%, while the annual FY2015 figure was $349000.0, 80.17% down from the prior year.
  • Long-Term Investments reached $77000.0 in Q2 2016 per NWBO's latest filing, down from $214000.0 in the prior quarter.
  • Across five years, Long-Term Investments topped out at $1.8 million in Q4 2014 and bottomed at $17000.0 in Q4 2012.
  • Average Long-Term Investments over 5 years is $394923.1, with a median of $77000.0 recorded in 2016.
  • Peak YoY movement for Long-Term Investments: soared 2296.36% in 2015, then plummeted 89.58% in 2016.
  • A 5-year view of Long-Term Investments shows it stood at $17000.0 in 2012, then changed by 0.0% to $17000.0 in 2013, then soared by 10252.94% to $1.8 million in 2014, then tumbled by 80.17% to $349000.0 in 2015, then crashed by 77.94% to $77000.0 in 2016.
  • Per Business Quant database, its latest 3 readings for Long-Term Investments were $77000.0 in Q2 2016, $214000.0 in Q1 2016, and $349000.0 in Q4 2015.